期刊文献+

1040株人型结核分枝杆菌耐药性分析 被引量:6

7Analysis of drug resistance of 1 040 Mycobacterium tuberculosis strains
原文传递
导出
摘要 目的分析研究汕头市第三人民医院2012~2013年肺结核患者结核分枝杆菌耐药性。方法对汕头市第三人民医院2012—2013年收集的结核分枝杆菌用WHO推荐的比例法进行异烟肼(H)、利福平(R)、链霉素(S)、乙胺丁醇(E)、左氧氟沙星(Lfx)、丙硫异烟胺(Pto)、卷曲霉素(Cm)、丁胺卡那(Am)、对氨基水杨酸(PAS)和卡那霉素(Km)的耐药性检测。结果2012年458株结核分枝杆菌中有135株耐药,总耐药率为29.5%(135/458);耐多药(MDR)率为14.4%(66/458)。耐单药顺位从高到低依次为H、S、R、E、Lfx、Pto、Cm、Am、PAS和Km。2013年582株结核分枝杆菌中有198株耐药,总耐药率为34.0%(198/582);耐多药(MDR)率为16.1%(94/582)。耐单药顺位从高到低依次为S、H、R、E、Lfx、Km、Cm、Am、PAS和Pto。结论结核分枝杆菌的耐药率仍然较高,临床应加强监测,指导防控工作和临床合理用药。 Objective To analyze the primary drug resistance of Myeobacterium tuberculosis in Shantou Third People' s hospital during 2012-2013. Methods Pmpertion method was used for testing drug susceptibility of Myeobacterium tuberculosis to isoniazid (H), rifampicin (R), streptomycin (S),ethambutol (E),levofloxacin (Lfx),protionamide(Pto), capreomycin (Cm) ,amikaein (Am), para-aminosalicylie acid (PAS) and kanamycin (Kin) according to the WHO guidelines for surveillance of drug resistance of Mycobacterium tuberculosis.Results The total resistant rate of 135 Mycobaeterium tuberculosis strains to antituberculosis drugs was 29.5% (135/458). The multiple drug resistance of Myeobacterium tuberculosiswas 14.4% (66/458). Drug resistance from high to low were in the order of H, S, R, E, Lfx, Pto, Cm, Am, PAS and KM respectively in 2012.The resistant rate of Mycobacterium tuberculosis in 2013 was 33.7% (198/582) and the multiple drug resistance was 16.1%(94/582). Drug resistance rate from high to low was in the order of S, H, R, E, Lfx, Km, Cm, Am, PAS and Pto. Conclsuion The resistance rate of Mycobacterium tuberculosis is still high and monitoring work be conducted for guidance of clinical treatment.
出处 《中国热带医学》 CAS 2014年第6期749-750,共2页 China Tropical Medicine
关键词 分枝杆菌 结核病 药物耐受性 预防 Myeobacterium tuberculosis , Tuberculosisi Drug tolerance Prevention
  • 相关文献

参考文献6

二级参考文献31

  • 1孙冰梅,车志宏.结核分枝杆菌耐药的分子机制及耐药基因检测方法的研究进展[J].山西医药杂志,2005,34(4):301-303. 被引量:13
  • 2杨桦.石家庄市肺结核病人耐药结果分析[J].中国卫生检验杂志,2006,16(8):999-1000. 被引量:2
  • 3中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007—2008年)[R].北京:人民卫生出版社.2010.
  • 4WHO/IUATLD global working group on anti-tuberculosis drug resistance surveillance.Guidelines for surveillance of drug resistance in tuberculoisis[M].Geneva:WHO,1997:2216.
  • 5World Health Organization. Global tuberculosis control: WHO report 2010[R]. WHO/HTM/TB/2010: 5-7.
  • 6卫生部疾病预防控制局,中国疾病预防控制中心.痰涂片镜检标准化操作及质量保证手册[S].北京:中国协和医科大学出版社,2008:2-24.
  • 7World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB), recommendations for prevention and control [J]. Wkly Epidemiol Ree,2006,81(45) ,430-432.
  • 8Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health[J]. N Engl J Med,2007,356(7):656-659.
  • 9Haydel SE, Extensively drug-resistant tuberculosis: a sign ofthe times and an impetus for antimicrobial discovery[J]. Pharmaceuticals(Basel), 2010,3(7): 2268-2290.
  • 10World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis-emergency update 2008[S]. WHO/HTM/TB/2008,402 : 135-139.

共引文献69

同被引文献52

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部